Product Information

NYSTATIN 100,000 UNIT/ML SUSP is a generic product labeled by PAI Holdings LLC, priced at $0.0529 per ML under NDC 00121086816. Its NADAC has been published 324 times since Sep 9, 2020.

FDA first approved this application on Jan 7, 2016. Its Orange Book therapeutic-equivalence code is AA.

NYSTATIN 100,000 UNIT/ML SUSP

NYSTATIN
$0.0529per ML

Strength

100000 [USP'U]/mL

Manufacturer

PAI Holdings LLC

NDC

00121086816

Classification

Generic

Dosage Form

SUSPENSION

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

NYSTATIN

Approval Type

Generic (ANDA)

FDA Application

ANDA203621

FDA Approved

1/7/2016

TE Code

AA

On Market Since

7/17/2020

Pharmacological Classes

Price Statistics

The NADAC for NYSTATIN 100,000 UNIT/ML SUSP has been published 324 times since Sep 9, 2020, and over the history we have for it it has declined 23.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0529 per ML
All-time high$0.0841 (Nov 11, 2020)
All-time low$0.0373 (Sep 21, 2022)
52-week high$0.0652
52-week low$0.0529
Median price$0.0563
Average price$0.0552
Largest weekly change+50.7% (Oct 21, 2020)
Weeks tracked324
Tracking sinceSep 9, 2020

Price History

1W

-4.4%

1M

-7.1%

3M

-9.5%

6M

-12.5%

1Y

-15.4%

3Y

+10.7%

5Y

-12.5%

All

-23.1%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of NYSTATIN 100,000 UNIT/ML SUSP?

The current National Average Drug Acquisition Cost (NADAC) for NYSTATIN 100,000 UNIT/ML SUSP, manufactured by PAI Holdings LLC, is $0.0529 per ML (NDC 00121086816), effective Nov 18, 2026.

How has the price of NYSTATIN 100,000 UNIT/ML SUSP changed over time?

Over the history we have for it, the NADAC for NYSTATIN 100,000 UNIT/ML SUSP has declined 23.1%. It has been tracked across 324 weekly CMS publications since Sep 9, 2020.

What are the highest and lowest recorded NADAC prices for NYSTATIN 100,000 UNIT/ML SUSP?

Since Sep 9, 2020, the NADAC for NYSTATIN 100,000 UNIT/ML SUSP has ranged from a low of $0.0373 (Sep 21, 2022) to a high of $0.0841 (Nov 11, 2020), with a median of $0.0563 per ML.

Are there cheaper alternatives to NYSTATIN 100,000 UNIT/ML SUSP?

4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as NYSTATIN 100,000 UNIT/ML SUSP in a comparable dosage form, but none are currently priced below it.

Who manufactures NYSTATIN 100,000 UNIT/ML SUSP?

NYSTATIN 100,000 UNIT/ML SUSP (NDC 00121086816) is labeled by PAI Holdings LLC, and CMS classifies it as a generic product.